Free Trial

EKF Diagnostics Final Earnings Report

EKF Diagnostics logo
GBX 21.90 +0.70 (+3.30%)
As of 03/28/2025 12:41 PM Eastern

EKF Diagnostics EPS Results

Actual EPS
GBX 1.38
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

EKF Diagnostics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

EKF Diagnostics Announcement Details

Quarter
Final
Time
Before Market Opens

Conference Call Resources

Remove Ads

EKF Diagnostics Earnings Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More EKF Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like EKF Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on EKF Diagnostics and other key companies, straight to your email.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

View EKF Diagnostics Profile

More Earnings Resources from MarketBeat